Evaluation of EverOn™ System in Medical / Surgical Ward
Launched by EARLYSENSE LTD. · Mar 20, 2008
Trial Information
Current as of July 21, 2025
Withdrawn
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age above 18 years.
- • 2. Patients not monitored continuously by telemetry, vital sign monitor or oximetry.
- • 3. Patients not requiring special mattresses (e.g. airflow).
- • 4. The patient or a legal guardian is ready to sign the Informed Consent.
- Exclusion Criteria:
- • 1. Patients that at the judgment of the staff in the evaluating unit, are not able to communicate coherently and respond to nurses' questions.
- • 2. Patients monitored continuously by telemetry, vital sign monitor or oximetry.
- • 3. Patients requiring special mattresses.
About Earlysense Ltd.
EarlySense Ltd. is a pioneering medical technology company specializing in non-invasive patient monitoring solutions designed to enhance clinical decision-making and improve patient outcomes. Utilizing advanced sensors and sophisticated algorithms, EarlySense's innovative platform continuously tracks vital signs and provides real-time insights into patient health, enabling healthcare providers to identify potential complications early and intervene proactively. Committed to advancing patient care, EarlySense collaborates with leading healthcare institutions to integrate its technology into clinical workflows, ultimately enhancing the quality of care in various medical settings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Framingham, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials